Literature DB >> 11237788

Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease.

M Koksch1, F Zeiger, K Wittig, A Siegemund, C B Reininger, D Pfeiffer, C Ruehlmann.   

Abstract

OBJECTIVES: to examine coagulation, fibrinolysis, and platelet activity in patients with peripheral vascular disease (PVD).
DESIGN: fifty consecutive PVD patients and 50 healthy volunteers. (Prospective comparative study.)
MATERIALS AND METHODS: P-selectin expression in non-fixed, whole blood was measured flow cytometrically on non-stimulated and ADP- and TRAP-6-stimulated samples. Plasma fibrinogen, von Willebrand factor (vWF), tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 were determined using standard techniques. Disease severity was stratified on the basis of the ankle-brachial pressure index (ABPI) and the angiographic data were assessed using the Bollinger score.
RESULTS: coagulation and fibrinolysis parameters as well as the P-selectin expression on both stimulated and non-stimulated platelets were significantly increased in patients vs controls (all p<0.01). The respective sensitivity and specificity were as follows: P-selectin expression (81%, 94%), vWF (72%, 86%), fibrinogen (64%, 98%), PAI-1 (44%, 90%), tPA (15%, 100%). P-selectin expression on TRAP-6-stimulated MP correlated with disease severity (r=0.40, p<0.01).
CONCLUSIONS: these findings support the concept of ongoing thrombogenesis in the subclinical progression of PVD and demonstrate the high diagnostic sensitivity of flow cytometric analysis of platelet activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237788     DOI: 10.1053/ejvs.2000.1294

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Rebecca Dann; Tarik Hadi; Emilie Montenont; Ludovic Boytard; Dornaszadat Alebrahim; Jordyn Feinstein; Nicole Allen; Russell Simon; Krista Barone; Kunihiro Uryu; Yu Guo; Caron Rockman; Bhama Ramkhelawon; Jeffrey S Berger
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

Review 2.  Antithrombotic treatment for peripheral arterial disease.

Authors:  Daniel G Hackam; John W Eikelboom
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

3.  Clot strength is negatively associated with ambulatory function in patients with peripheral artery disease and intermittent claudication.

Authors:  Karin Mauer; Andrew W Gardner; Tarun W Dasari; Julie A Stoner; Steve M Blevins; Polly S Montgomery; Jorge F Saucedo; J Emilio Exaire
Journal:  Angiology       Date:  2014-04-27       Impact factor: 3.619

Review 4.  Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation.

Authors:  Louis L Nguyen
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

5.  Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.

Authors:  Peter Paul Wisman; Martin Teraa; Gert Jan de Borst; Marianne C Verhaar; Mark Roest; Frans L Moll
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Authors:  Raul Altman; Héctor L Luciardi; Juan Muntaner; Ramón N Herrera
Journal:  Thromb J       Date:  2004-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.